Safety and efficacy of treatment with pegylated interferon alpha-2a with ribavirin in chronic hepatitis C genotype 4.
Urquijo JJ, Diago M, Boadas J, Planas R, Solá R, Del Olmo JA, Crespo J, Erdozaín JC, Antón MD, Arocena C, Suarez D, Giné J, Barrera JM, Gracia-Samaniego J, Perez R, Dalmau B, Montoro M.
Urquijo JJ, et al. Among authors: barrera jm.
Ann Hepatol. 2013 Jan-Feb;12(1):30-5.
Ann Hepatol. 2013.
PMID: 23293191
Free article.
Clinical Trial.